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Introduction
 Although conventional hearing aids can provide ample 
benefit for patients with mild to severe hearing loss, patients 
experience several problems including acoustic feedback, oc-
clusion effect, discomfort, infection, and unsatisfactory cos-
mesis. Active middle ear implants (AMEIs) may offer ade-
quate amplification without these problems [1,2]. The Vibrant 
Soundbridge (VSB, Med-El, Innsbruck, Austria) is a partial-
ly implantable AMEI device comprised of an internal compo-
nent that utilizes a vibrating ossicular prosthesis (VORP) and 
an external component with microphone, audio processor, bat-
tery, and transmitter coil. Sound information is collected and 
processed in the audio processor and delivered transcutane-
ously to the VORP. The transmitted electromagnetic signals 
are transformed to vibration energy that drives the floating 
mass transducer (FMT) by an electrical conduit. The VORP 
can be coupled to the ossicular chain (usually the incus, sta-
pes, or footplate) or to the round window [3-5]. Reports of au-
diological results and patient satisfaction are generally favor-
able for AMEI [2,6-9]. Studies have shown that functional gain 
and speech recognition scores were stable, and that subjective 
satisfaction with the AMEI was comparable to conventional 
hearing aids over a long term period of time [10,11]. Despite 
the expectation that the residual hearing is preserved and bet-
ter outcomes with AMEI, patients undergoing the AMEI sur-
gery may be distressed during the immediate postoperative 
period while the implanted ear is temporarily deprived of hear-
ing amplification. In this case report, we describe the changes 
of the postoperative audiologic outcomes in a case of AMEI 
using incus vibroplasty over 11 months postoperatively.
Case Report
A 68-year-old man presented to our department with de-
creased hearing acuity in both ears. The patient had a long-
standing history of chronic otitis media and had undergone tym-
panoplasty on the right side 8 years prior. He had been using 
conventional hearing aids in both ears on and off for 8 years. 
His main issues with the hearing aids were dissatisfaction with 
the quality of sound, difficulty with speech discrimination, 
and intermittent skin problems in the external auditory canal. 
Pure tone audiometry confirmed bilateral sensorineural hear-
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ing loss (SNHL) with increased thresholds at 3 kHz and high-
er (Fig. 1). Speech discrimination scores for two-syllable 
words were 72% in the right ear and 76% in the left, at presen-
tations level of 70 dB. Temporal bone computed tomography 
scans showed no active inflammatory changes, and the ossic-
ular chain appeared intact in both ears. During counseling for 
hearing rehabilitation, the option of using VSB was discussed 
with the patient. Since he preferred using a hearing aid in the 
left ear, surgery for VSB was performed in the right ear. Intra-
operatively, after mastoidectomy was performed to preserve 
the posterior external auditory canal wall, a facial recess was 
opened, and the long process of the incus was identified. Ex-
tra care was taken to widen the inferior portion of the facial 
recess to allow unhindered entrance of the FMT and the spe-
cialized forming forceps. Ossicular chain mobility was intact. 
After the VORP was secured in the bony well, the FMT was 
introduced into the middle ear cavity. The clip of the FMT 
was gently placed on the long process of the incus without 
any excess pressure to the ossicular chain. The axis of the 
FMT was aligned parallel to the axis of motion of the stapes, 
and care was taken to ensure that the FMT was close enough 
to the incudostapedial joint but did not touch the promontory or 
the pyramidal eminence. Then, the forming forceps were 
brought through the facial recess with the jaws opened. The 
forming forceps were centered exactly over the FMT clip, 
and then the jaws were closed to form the clip over the long 
process of the incus. The jaws were then carefully opened, and 
the forceps were retracted without causing trauma to the ossi-
cles (Fig. 2). A sharp pick was used to check the attachment 
of the clip to the incus, ensuring it was secure enough to hold 
the FMT in position. Intraoperative Auditory Nerve Re-
sponse Telemetry (Med-El, Innsbruck, Austria) confirmed 
the positioning of the FMT, and immediate postoperative 
transocular orbital view confirmed the implanted device (Fig. 
3). Audiogram showed increased thresholds at 250 and 500 
Hz at 8 weeks after the surgery, and with the initial mapping, 
a functional gain of 20-30 dB was achieved (Fig. 4A). Dur-
ing the following 6 months, the air-bone gap noted in the lower 
frequencies resolved, and the hearing thresholds returned to 
preoperative levels (Fig. 4B). At 11 months postoperatively, 
residual hearing was preserved, and the functional gain had 
increased to 30-40 dB at 2 and 4 kHz (Fig. 4C). Further-
more, the patient reported better sound quality and more natu-
ral voice perception.
Fig. 1. Preoperative pure tone audiogram shows bilateral sensori-
neural hearing loss.
Fig. 2. Intraoperative photo shows the floating mass transducer of 
the middle ear implant is fixed onto the long process of the incus.
Fig. 3. Immediate postoperative transocular orbital view confirmed 
the positioning of the implanted device.
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er and the forming forceps to ensure that working space with-
in the facial recess is adequate for the following procedures. 
The most important step of incus vibroplasty is securing the 
attachment clip on the long process of the incus, which may 
cause significant trauma. The surgeon’s hand should be kept 
steady and excess pressure must be avoided when closing 
the crimp on the incus. Also, repeated manipulation of the 
FMT should be avoided. The FMT must be positioned paral-
lel to the stapes but not contacting the promontory. The role 
of perioperative glucocorticoids has been described for co-
chlear implant operations, and they may be helpful for mid-
dle ear implant operations as well. During the postoperative 
period, the hearing thresholds were elevated but returned to 
initial levels at switch-on about 6 months postoperatively. 
This transient air-bone gap could partially be attributed to 
blood collection or the use of gelfoam and fibrin glue in the 
middle ear cavity. Delay in formation of fibrotic adhesion 
between the FMT and the incus long process may be another 
factor. Previous studies have ascribed postoperative hearing 
deterioration to middle ear problems or injury to the ossicles 
[1,13]. Initial mapping is usually recommended about 8 weeks 
after the surgery to allow a secure connection between the 
FMT and the ossicular chain. In our patient, the air-bone gap 
persisted up to 6 months although adequate gain could be 
achieved through the device. A possible explanation may be 
that surgical trauma resulted in temporary hypermobility of 
the ossicular chain causing the air-bone gap, but the direct 
drive of FMT was sufficient to overcome the burden. In sum-
mary, although an increased air-bone gap in residual hearing 
persisted for up to 6 months, residual hearing could be pre-
served long-term after the incus vibroplasty technique. 
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Discussion
Hearing loss is one of the most prevalent chronic conditions, 
and prevalence increases with age. However, a significant 
portion of candidates are not able to tolerate conventional hear-
ing aids. Acoustic feedback, occlusion effect, frequent battery 
changes, discomfort, infection, and cosmetic problems are 
among the numerous reasons for low compliance. AMEIs of-
fer several advantages for patients with SNHL who cannot tol-
erate conventional hearing aids, because the device is semi-
implantable and the implanted magnetic actuator directly 
stimulates the ossicles in the middle ear. One of the concerns 
patients express when presented with the options for hearing 
rehabilitation is whether their residual hearing can be pre-
served after implantation surgery. Audiological outcomes of 
VSB have been reported to be favorable, and the functional 
gain of the VSB remained stable postoperatively [8,10,12,13]. 
Residual hearing in the implanted ears was comparable to the 
contralateral ears, and the functional gain remained stable 
over 5-8 years after surgery [11]. Likewise, residual hearing 
was relatively stable for 8 months in our patient with no sig-
nificant change.
Incus vibroplasty involves handling of the normally func-
tioning ossicular chain and carries the potential of damage to 
the ossicles or the cochlear duct. In contrast to conventional 
cochlear implantees whose residual hearing is minimal, it is 
important for the candidates of middle ear implants to retain 
their residual hearing ability without their devices. Thus, ut-
most care must be taken during the implant surgery. During 
mastoidectomy, damage to the ossicles, usually the incus, 
should be avoided. In order to obtain adequate working space 
for the forming forceps, the facial recess needs to be widened. 
When using small burrs to widen the superior margin of the 
facial recess, direct trauma to the incus or the incudostapedi-
al joint should be avoided. Before the FMT is introduced into 
the middle ear cavity, it is advisable to use both the FMT siz-
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Fig. 4. A: At initial mapping, a functional gain of 20-30 dB was achieved. B: During the following 6 months, the air-bone gap noted in the 
lower frequencies resolved, and hearing thresholds returned to preoperative levels. C: At 11 months postoperatively, residual hearing was 
preserved and functional gain of 30-40 dB was achieved at 2 and 4 kHz.
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